Nutritional Management of Chronic Kidney Disease

Course Description:

Discover evidence-based strategies for the nutritional management of chronic kidney disease (CKD), with a focus on identifying, preventing, and treating protein-energy wasting (PEW) across the disease continuum. This course equips healthcare professionals with practical guidance on comprehensive nutritional assessment, interpretation of key clinical markers, and implementation of guideline-aligned protein and energy interventions for non-dialysis and dialysis patients. Clinicians will explore the evolving role of oral nutritional supplementation, particularly renal-specific formulations, in optimizing nutritional status, supporting quality of life, and potentially improving clinical outcomes.

Course Objectives:

• Review the epidemiology, pathophysiology and diagnosis of protein-energy wasting (PEW) in chronic kidney disease (CKD) and end-stage renal disease (ESRD).
• Describe guideline-recommended nutritional interventions for patients with CKD and end-stage renal disease (ESRD).
• Discuss the role of renal-specific oral nutritional supplements in the management of CKD and ESRD.

Key Takeaways:

• Chronic kidney disease (CKD) affects a large number of patients with significant deleterious consequences.
• Protein-energy wasting (PEW) is common in CKD and is associated with adverse outcomes.
• Dietary interventions are a core component of CKD management, addressing both PEW and progression of CKD.
• The application of renal oral nutrition supplementation can help achieve nutritional goals in patients with CKD and end-stage renal disease. 

Related Questions:

• How should protein and energy intake be optimized across different stages of chronic kidney disease (CKD) without worsening disease progression?
  Optimizing protein and energy intake in CKD requires a careful balance between slowing disease progression and preventing protein-energy wasting (PEW). In the earlier stages of CKD, controlled protein restriction can help reduce nitrogenous waste, proteinuria, and intraglomerular pressure, yet overly aggressive restriction risks malnutrition if energy intake is inadequate. As patients progress to dialysis, protein needs increase substantially to offset catabolic stressors and dialysis-related losses.
  
• What are the most reliable ways to identify and diagnose PEW in patients with CKD?
  PEW is common, underdiagnosed, and strongly associated with poor outcomes, including higher mortality and hospitalization rates. However, no single biomarker or tool is sufficient for diagnosis. Instead, clinicians must integrate multiple domains, including biochemical markers such as albumin, body composition, muscle mass, and dietary intake, as well as longitudinal trends.
• When and how should oral nutritional supplements be used in CKD, and what makes renal-specific formulations different?
  Oral nutritional supplementation plays an increasingly important role when dietary counseling alone cannot meet protein and energy needs, especially in patients at risk for or already experiencing PEW. Renal-specific formulations are uniquely designed to align with CKD requirements, offering tailored protein content, lower electrolyte burden, higher caloric density, and glycemic considerations for patients with comorbid diabetes.